186 related articles for article (PubMed ID: 28596173)
1. Forging the Fate of Cellular Therapies for Cardiovascular Disease.
Simari RD
Circ Res; 2017 Jun; 120(12):1871-1873. PubMed ID: 28596173
[TBL] [Abstract][Full Text] [Related]
2. [Safety cell therapeutics/cell based medicinal products (CBMP)].
Scherer J; Seitz R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1199-200. PubMed ID: 26391096
[No Abstract] [Full Text] [Related]
3. Induced pluripotent stem cells for the study of cardiovascular disease.
Savla JJ; Nelson BC; Perry CN; Adler ED
J Am Coll Cardiol; 2014 Aug; 64(5):512-9. PubMed ID: 25082586
[TBL] [Abstract][Full Text] [Related]
4. Regulation Policy for Cell and Tissue Therapies in Australia.
Sturm M
Tissue Eng Part A; 2015 Dec; 21(23-24):2797-801. PubMed ID: 26096750
[TBL] [Abstract][Full Text] [Related]
5. Natural Therapies for Cardiovascular Diseases.
Yang X; Yang G; Caminiti G; Borrelli F
Biomed Res Int; 2016; 2016():4624378. PubMed ID: 28097134
[No Abstract] [Full Text] [Related]
6. Teeth-derived stem cells: A source for cell therapy.
Baniebrahimi G; Khanmohammadi R; Mir F
J Cell Physiol; 2019 Mar; 234(3):2426-2435. PubMed ID: 30238990
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Therapeutics for Cardiac Regeneration.
Lei Z; Sluijter JP; van Mil A
Mini Rev Med Chem; 2015; 15(6):441-51. PubMed ID: 25807943
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders. Part 1: Conventional Therapy.
Orekhov AN; Ivanova EA
Curr Pharm Des; 2017; 23(6):859-860. PubMed ID: 28590230
[No Abstract] [Full Text] [Related]
9. Concise review: cell therapy and tissue engineering for cardiovascular disease.
Haraguchi Y; Shimizu T; Yamato M; Okano T
Stem Cells Transl Med; 2012 Feb; 1(2):136-41. PubMed ID: 23197760
[TBL] [Abstract][Full Text] [Related]
10. Regenerative therapies for improving myocardial perfusion in patients with cardiovascular disease: failure to meet expectations but optimism for the future.
Sellke FW; Lassaletta AD; Robich MP; Chu LM; Ruel M
Curr Vasc Pharmacol; 2012 May; 10(3):300-9. PubMed ID: 22239632
[TBL] [Abstract][Full Text] [Related]
11. The birth of 'regenerative pharmacology': a clinical perspective.
Choudhury TR; Mathur A
Br J Pharmacol; 2013 May; 169(2):239-46. PubMed ID: 23425309
[No Abstract] [Full Text] [Related]
12. Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN.
Park KE; Moyé LA; Henry TD; Perin EC; Sayre SL; Bettencourt J; Vojvodic RW; Olson RE; Pepine CJ;
Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1495-502. PubMed ID: 24147517
[TBL] [Abstract][Full Text] [Related]
13. Nutriceuticals as treatments for cardiovascular disease.
Frishman WH
Heart Dis; 1999; 1(2):51. PubMed ID: 11727679
[No Abstract] [Full Text] [Related]
14. Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective.
Psaltis PJ; Simari RD; Rodriguez-Porcel M
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):165-81. PubMed ID: 21901381
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Diseases and Natural Products.
Chen Z; Liu Z; Peng Y; Leng L; Du L; Xu T; Wang D
Curr Protein Pept Sci; 2019; 20(10):962-963. PubMed ID: 31592748
[No Abstract] [Full Text] [Related]
16. Cardiovascular repair and regeneration 2008: the fourth International Conference on Cell Therapy for Cardiovascular Disease (IC3D).
Sherman W; Dimmeler S; Hare JM; Penn M
EuroIntervention; 2008 May; 4(1):47-9. PubMed ID: 19112777
[TBL] [Abstract][Full Text] [Related]
17. Current and Future Cell Therapy Standards and Guidelines.
Atkins JW; West K; Kasow KA
Hematol Oncol Clin North Am; 2019 Oct; 33(5):839-855. PubMed ID: 31466608
[TBL] [Abstract][Full Text] [Related]
18. Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy.
Bianconi V; Sahebkar A; Kovanen P; Bagaglia F; Ricciuti B; Calabrò P; Patti G; Pirro M
Pharmacol Ther; 2018 Jan; 181():156-168. PubMed ID: 28827151
[TBL] [Abstract][Full Text] [Related]
19. [Experimental rationale and trial of the therapeutic use of bee-raising products in cardiovascular diseases].
Liusov VA; Zimin IuV
Kardiologiia; 1983 May; 23(5):105-10. PubMed ID: 6348365
[No Abstract] [Full Text] [Related]
20. [Classification of cell-based medicinal products and legal implications: An overview and an update].
Scherer J; Flory E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1201-6. PubMed ID: 26369760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
